Buffer Ph Tablet, Chewable
NDC Package 70163-0043-1
Package Information
Buffer Ph (chamomilla, graphites, kali carbonicum, kali oxalicum, kali phosphoricum, magnesia phosphorica, natrum muriaticum, natrum phosphoricum, natrum sulphuricum, nux vomica, rheum (palmatum), robinia pseudoacacia) tablets is adults and children 12 years and over: ■ chew one tablet and allow to dissolve in the mouth up to 4 times daily. This formulation utilizes a tablet, chewable delivery system. Marketed by Naturalcare, this product is identified by NDC 70163-0043.
Identification & Billing
Clinical Specifications
- DIBASIC POTASSIUM PHOSPHATE 6 [hp_X]/1
- GRAPHITE 6 [hp_C]/1
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/1
- MATRICARIA CHAMOMILLA WHOLE 6 [hp_X]/1
- POTASSIUM CARBONATE 6 [hp_X]/1
- POTASSIUM OXALATE 6 [hp_X]/1
- RHEUM PALMATUM ROOT 6 [hp_X]/1
- ROBINIA PSEUDOACACIA BARK 6 [hp_X]/1
- SODIUM CHLORIDE 6 [hp_X]/1
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 6 [hp_X]/1
- SODIUM SULFATE 6 [hp_X]/1
- STRYCHNOS NUX-VOMICA SEED 30 [hp_X]/1
- Allergens - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Seed Storage Proteins - [CS]
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 70163 - Naturalcare
- 70163-0043 - Buffer Ph
- 70163-0043-1 - 1 BLISTER PACK in 1 CARTON / 60 TABLET, CHEWABLE in 1 BLISTER PACK
- 70163-0043 - Buffer Ph
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70163-0043-1 identifies a specific commercial package of 1 blister pack in 1 carton / 60 tablet, chewable in 1 blister pack of Buffer Ph, a human over the counter drug labeled by Naturalcare. This tablet, chewable is formulated for oral use and contains dibasic potassium phosphate; graphite; magnesium phosphate, dibasic trihydrate; matricaria chamomilla whole; potassium carbonate; potassium oxalate; rheum palmatum root; robinia pseudoacacia bark; sodium chloride; sodium phosphate, dibasic, heptahydrate; sodium sulfate; strychnos nux-vomica seed as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Naturalcare on March 25, 2026. The current certification is valid through December 31, 2027.
How is this Naturalcare product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70163004301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.